These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29316528)

  • 1. Altered structural network organization in cognitively normal individuals with amyloid pathology.
    Voevodskaya O; Pereira JB; Volpe G; Lindberg O; Stomrud E; van Westen D; Westman E; Hansson O
    Neurobiol Aging; 2018 Apr; 64():15-24. PubMed ID: 29316528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease.
    Wang L; Benzinger TL; Hassenstab J; Blazey T; Owen C; Liu J; Fagan AM; Morris JC; Ances BM
    Neurology; 2015 Mar; 84(12):1254-60. PubMed ID: 25716355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral changes and disrupted gray matter cortical networks in asymptomatic older adults at risk for Alzheimer's disease.
    Cantero JL; Atienza M; Sanchez-Juan P; Rodriguez-Rodriguez E; Vazquez-Higuera JL; Pozueta A; Gonzalez-Suarez A; Vilaplana E; Pegueroles J; Montal V; Blesa R; Alcolea D; Lleo A; Fortea J
    Neurobiol Aging; 2018 Apr; 64():58-67. PubMed ID: 29331877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.
    Doré V; Villemagne VL; Bourgeat P; Fripp J; Acosta O; Chetélat G; Zhou L; Martins R; Ellis KA; Masters CL; Ames D; Salvado O; Rowe CC
    JAMA Neurol; 2013 Jul; 70(7):903-11. PubMed ID: 23712469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid β-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease.
    Fortea J; Vilaplana E; Alcolea D; Carmona-Iragui M; Sánchez-Saudinos MB; Sala I; Antón-Aguirre S; González S; Medrano S; Pegueroles J; Morenas E; Clarimón J; Blesa R; Lleó A;
    Ann Neurol; 2014 Aug; 76(2):223-30. PubMed ID: 24852682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-reported traumatic brain injury and in vivo measure of AD-vulnerable cortical thickness and AD-related biomarkers in the ADNI cohort.
    Wang ML; Wei XE; Yu MM; Li PY; Li WB;
    Neurosci Lett; 2017 Aug; 655():115-120. PubMed ID: 28689050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease.
    Thordardottir S; Ståhlbom AK; Ferreira D; Almkvist O; Westman E; Zetterberg H; Eriksdotter M; Blennow K; Graff C
    J Alzheimers Dis; 2015; 43(4):1393-402. PubMed ID: 25182737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic correlates of cortical thickness in cognitively normal individuals with normal and abnormal cerebrospinal fluid beta-amyloid
    Ekblad LL; Visser PJ; Tijms BM;
    Neurobiol Aging; 2021 Nov; 107():42-52. PubMed ID: 34375908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease.
    Vlassenko AG; McCue L; Jasielec MS; Su Y; Gordon BA; Xiong C; Holtzman DM; Benzinger TL; Morris JC; Fagan AM
    Ann Neurol; 2016 Sep; 80(3):379-87. PubMed ID: 27398953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging β-amyloid pathology and accelerated cortical atrophy.
    Mattsson N; Insel PS; Nosheny R; Tosun D; Trojanowski JQ; Shaw LM; Jack CR; Donohue MC; Weiner MW;
    JAMA Neurol; 2014 Jun; 71(6):725-34. PubMed ID: 24781145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.
    Bousiges O; Cretin B; Lavaux T; Philippi N; Jung B; Hezard S; Heitz C; Demuynck C; Gabel A; Martin-Hunyadi C; Blanc F
    J Alzheimers Dis; 2016; 51(4):1069-83. PubMed ID: 26923009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal brain structural changes in preclinical Alzheimer's disease.
    Pegueroles J; Vilaplana E; Montal V; Sampedro F; Alcolea D; Carmona-Iragui M; Clarimon J; Blesa R; Lleó A; Fortea J;
    Alzheimers Dement; 2017 May; 13(5):499-509. PubMed ID: 27693189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-amyloid pathology and hippocampal atrophy are independently associated with memory function in cognitively healthy elderly.
    Svenningsson AL; Stomrud E; Insel PS; Mattsson N; Palmqvist S; Hansson O
    Sci Rep; 2019 Aug; 9(1):11180. PubMed ID: 31371787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease.
    Voevodskaya O; Sundgren PC; Strandberg O; Zetterberg H; Minthon L; Blennow K; Wahlund LO; Westman E; Hansson O;
    Neurology; 2016 May; 86(19):1754-61. PubMed ID: 27164711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying earlier Alzheimer's disease: insights from the preclinical and prodromal phases.
    Molinuevo JL; Sánchez-Valle R; Lladó A; Fortea J; Bartrés-Faz D; Rami L
    Neurodegener Dis; 2012; 10(1-4):158-60. PubMed ID: 22156554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity.
    Palmqvist S; Schöll M; Strandberg O; Mattsson N; Stomrud E; Zetterberg H; Blennow K; Landau S; Jagust W; Hansson O
    Nat Commun; 2017 Oct; 8(1):1214. PubMed ID: 29089479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation, Amyloid, and Atrophy in The Aging Brain: Relationships with Longitudinal Changes in Cognition.
    Sala-Llonch R; Idland AV; Borza T; Watne LO; Wyller TB; Brækhus A; Zetterberg H; Blennow K; Walhovd KB; Fjell AM
    J Alzheimers Dis; 2017; 58(3):829-840. PubMed ID: 28505968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.
    Sutphen CL; Jasielec MS; Shah AR; Macy EM; Xiong C; Vlassenko AG; Benzinger TL; Stoops EE; Vanderstichele HM; Brix B; Darby HD; Vandijck ML; Ladenson JH; Morris JC; Holtzman DM; Fagan AM
    JAMA Neurol; 2015 Sep; 72(9):1029-42. PubMed ID: 26147946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.